MOLECULAR INFORMATION
Molecular information
- Type
- Short peptide bioregulator · claimed ovarian / hepatic tissue modulator
Ovagen is one of the Khavinson family of “short bioregulator peptides”.
Claims vs evidence
- Hepatic tissue support — preclinical only, single-group
- Female-reproductive support — vendor-specific claim, no Western RCT
Why we grade it D
Same single-source evidence pattern as the rest of the Khavinson family.
Frequently asked questions
- What is Ovagen?
- A short Khavinson-family bioregulator peptide marketed primarily for hepatic tissue support, with secondary claims around ovarian and female-reproductive function depending on the vendor.
- Is Ovagen authorised?
- No — not authorised by EMA, FDA, MHRA or Swissmedic. Sold grey-market.
- Why grade D?
- Single-research-group evidence pattern as the rest of the Khavinson family. Mechanism framework not recognised in mainstream endocrinology or hepatology.